001     293998
005     20241128083017.0
037 _ _ |a DKFZ-2024-02038
100 1 _ |a Schönfelder, Bruno
|0 P:(DE-He78)af9892a34bf8a8a9cf0e7a11a8617645
|b 0
|u dkfz
245 _ _ |a Functional validation of patient-derivedmyeloma-reactive T cell receptors
260 _ _ |c 2024
336 7 _ |a Output Types/Supervised Student Publication
|2 DataCite
336 7 _ |a Thesis
|0 2
|2 EndNote
336 7 _ |a MASTERSTHESIS
|2 BibTeX
336 7 _ |a masterThesis
|2 DRIVER
336 7 _ |a Master Thesis
|b master
|m master
|0 PUB:(DE-HGF)19
|s 1732778994_23104
|2 PUB:(DE-HGF)
336 7 _ |a SUPERVISED_STUDENT_PUBLICATION
|2 ORCID
500 _ _ |a Verteidigung 8.1.24
502 _ _ |a Masterarbeit, Universität Heidelberg, 2024
|c Universität Heidelberg
|b Masterarbeit
|g Fakultät für Biowissenschaften
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
909 C O |p VDB
|o oai:inrepo02.dkfz.de:293998
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)af9892a34bf8a8a9cf0e7a11a8617645
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2024
920 1 _ |0 I:(DE-He78)D210-20160331
|k D210
|l GMP-Einheit Zelluläre Therapie
|x 0
980 _ _ |a master
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D210-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21